Nueclear Healthcare opens its first molecular imaging centre in Navi Mumbai
Nueclear Healthcare, in association with GE Healthcare as technology partner, announced the opening of its first molecular imaging centre for early and affordable cancer detection in Navi Mumbai. NHL is establishing a mega network of 120 molecular imaging centres in India by 2015 with GE Healthcare as its technology partner. The hub and spoke model is expected to help scale up affordable access to advanced molecular imaging technologies such as PET/CT required early detection of cancer. NHL proposes to offer PET/CT imaging at just Rs 10,000/- compared to approximately Rs 18000- 25000 patients pay today for same services.
“At GE, we envision a day when cancer is no longer a deadly disease. Today’s event reinforces our commitment to cancer and reflects our current integrated portfolio and GE Healthcare’s $1B R&D investment to advance oncology solutions by 2016,” said John Dineen, President & CEO, GE Healthcare. “Scaling up of cancer diagnosis and treatment requires disruptive innovations and willing partners. By partnering with Nueclear Healthcare, together we can be at work for a healthier India by providing access to advanced affordable early cancer detection technologies to more people of India.”
The NHL network of molecular imaging centres will have 12 medical cyclotrons that produce bio-markers required for cancer imaging and 120 GE Discovery PET/CT imaging scanners. While the first centre is opened today at Navi Mumbai, five more centres is expected to be commissioned in 2013. GE Discovery PET/CT systems installed at the centre will help doctors determine whether a suspicious growth is cancerous or benign in a single exam. Previously, doctors had to put patients through two separate scans to get similar information—with limited success.
“Cost has been one of the biggest barriers in advancing early cancer detection. We have removed the barrier of cost by reducing the cost to patient by half. We are following the same concept which made Thyrocare, a household name today. If we make detection and treatment affordable, more people will come forward and the sheer volume will take care of our capital investments. We have a great partner in GE Healthcare and our visions match—make India a healthier country,” said Dr A Velumani, Founder & MD of Nueclear Healthcare.
EH News Bureau
- Advertisement -